Accrual and retention of diverse patients in psychosocial cancer clinical trials

被引:5
|
作者
Hanvey, Grace Ann [1 ]
Padron, Adaixa [1 ]
Kacel, Elizabeth L. [1 ]
Cartagena, Gabriel [1 ]
Bacharz, Kelsey C. [1 ]
McCrae, Christina S. [1 ]
Robinson, Michael E. [1 ]
Waxenberg, Lori B. [1 ]
Antoni, Michael H. [2 ]
Berry, Richard B. [3 ]
Schultz, Gregory S. [4 ]
Castagno, Jacqueline [4 ]
Pereira, Deidre B. [1 ]
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA
[2] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
[3] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA
[4] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Cancer; clinical trials; recruitment; retention; health disparities; SLEEP QUALITY INDEX; PSYCHOMETRIC PROPERTIES; PARTICIPATION; POPULATIONS; MINORITIES; INVENTORY; BARRIERS; HEALTH; PAIN;
D O I
10.1017/cts.2022.380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to examine sociodemographic inequities in CCT interest, eligibility, enrollment, decline motivation, and attrition across two psychosocial CCTs for gynecologic, gastrointestinal, and thoracic cancers. Methods: Patients were approached for recruitment to one of two interventions: (1) a randomized control trial (RCT) examining effects of a cognitive-behavioral intervention targeting sleep, pain, mood, cytokines, and cortisol following surgery, or (2) a yoga intervention to determine its feasibility, acceptability, and effects on mitigating distress. Prospective RCT participants were queried about interest and screened for eligibility. All eligible patients across trials were offered enrollment. Patients who declined yoga intervention enrollment provided reasons for decline. Sociodemographic predictors of enrollment decisions and attrition were explored. Results: No sociodemographic differences in RCT interest were observed, and older patients were more likely to be ineligible. Eligible Hispanic patients across trials were significantly more likely to enroll than non-Hispanic patients. Sociodemographic factors predicted differences in decline motivation. In one trial, individuals originating from more urban areas were more likely to prematurely discontinue participation. Discussion: These results corroborate evidence of no significant differences in CCT interest across minority groups, with older adults less likely to fulfill eligibility criteria. While absolute Hispanic enrollment was modest, Hispanic patients were more likely to enroll relative to non-Hispanic patients. Additional sociodemographic trends were noted in decline motivation and geographical prediction of attrition. Further investigation is necessary to better understand inequities, barriers, and best recruitment practices for representative CCTs.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
    Hamm, Caroline
    Cavallo-Medved, Dora
    Moudgil, Devinder
    McGrath, Lee
    Huang, John
    Li, Yueyang
    Stratton, Tyler W.
    Robinson, Tyler
    Naccarato, Krista
    Sundquist, Stephen
    Dancey, Janet
    CANCER CONTROL, 2022, 29
  • [22] Clinical trials knowledge and attitudes of Vietnamese- and Anglo-Australian cancer patients: A cross-sectional study
    Smith, Allan B.
    Niu, Anita Y.
    Descallar, Joseph
    Delaney, Geoff P.
    Wu, Verena S.
    Agar, Meera R.
    Girgis, Afaf
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (05) : E242 - E251
  • [23] Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials
    Buttgereit, Thomas
    Palmowski, Andriko
    Forsat, Noah
    Boers, Maarten
    Witham, Miles D.
    Rodondi, Nicolas
    Moutzouri, Elisavet
    Quesada Navidad, Antonio Jesus
    van't Hof, Arnoud W. J.
    van der Worp, Bart
    Coll-Planas, Laura
    Voshaar, Marieke
    de Wit, Maarten
    da Silva, Jose
    Stegemann, Sven
    Bijlsma, Johannes W.
    Koeller, Marcus
    Mooijaart, Simon
    Kearney, Patricia M.
    Buttgereit, Frank
    AGE AND AGEING, 2021, 50 (06) : 1988 - 1996
  • [24] Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual
    Hoin, Jon A.
    Carthon, Bradley C.
    Brown, Shantoria J.
    Durham, Lynn M.
    Garrot, L. Crain
    Ghamande, Sharad A.
    Pippas, Andrew W.
    Rivers, Brian M.
    Snyder, Cindy T.
    Gabram-Mendola, Sheryl Gordon Ann
    FRONTIERS IN HEALTH SERVICES, 2024, 4
  • [25] Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer
    Behrendt, Carolyn E.
    Hurria, Arti
    Tumyan, Lusine
    Niland, Joyce C.
    Mortimer, Joanne E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (11): : 1579 - 1585
  • [26] An Electronic Information Kiosk for Enhancing Patient Accrual for Cancer Clinical Trials: A Pilot and Feasibility Study
    Black, Morgan D.
    Esene, Lilian
    McClelland, Richard
    Mayer, Heather
    Welch, Stephen
    Bauman, Glenn
    Vandenberg, Theodore
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [27] Analysis of Maryland Cancer Patient Participation in National Cancer Institute-Supported Cancer Treatment Clinical Trials
    Baquet, Claudia R.
    Ellison, Gary L.
    Mishra, Shiraz I.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2009, 20 (02) : 120 - 134
  • [28] Suspension of accrual in phase II cancer clinical trials
    Li, Yimei
    Mick, Rosemarie
    Heitjan, Daniel F.
    CLINICAL TRIALS, 2015, 12 (02) : 34 - 44
  • [29] Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual
    Hillyer, Grace Clarke
    Park, Yeun-Hee Anna
    Rosenberg, Ta-Chueh Hsu
    Mundi, Prabhjot
    Patel, Imtiaz
    Bates, Susan E.
    SEMINARS IN ONCOLOGY, 2021, 48 (02) : 130 - 140
  • [30] Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?
    Hernandez-Torres, Catalina
    Cheung, Winson Y.
    Kong, Shiying
    O'Callaghan, Chris J.
    Hsu, Tina
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 455 - 462